METHODS OF TREATING INFLAMMATORY, FIBROTIC, AND PROLIFERATIVE CONDITIONS USING COMPOSITIONS COMPRISING DGLA AND/OR 15-HETRE, AND ASSOCIATED METHODS AND COMPOSITIONS

#11 | 2021-10-14

US20210315851A1

Human necessities

COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING OR PREVENTING HEMATOLOGIC DISORDERS, AND/OR RELATED DISEASES

#12 | 2021-08-12

US20210244697A1

Human necessities

COMPOSITIONS COMPRISING 15-OHEPA AND METHODS OF USING THE SAME

#13 | 2021-07-29

US20210230094A1

Chemistry; metallurgy

Compositions Comprising Oxo-Derivatives of Fatty Acids and Methods of Making and Using Same

#14 | 2021-07-29

US20210228524A1

Human necessities

COMPOSITIONS COMPRISING 15-OHEPA AND METHODS OF USING THE SAME

#15 | 2021-03-25

US20210085628A1

Human necessities

COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING OR PREVENTING CANCER AND NEUROLOGIC DISEASE

#16 | 2020-11-19

US20200360331A1

Human necessities

COMPOSITIONS COMPRISING 15-HEPE AND/OR 15-HETrE AND METHODS OF TREATING OR PREVENTING CARDIOMETABOLIC DISEASE, METABOLIC SYNDROME, AND/OR RELATED DISEASES

#17 | 2020-10-15

US20200323807A1

Human necessities

Pharmaceutical compositions comprising DGLA and use of same

#18 | 2020-03-05

US20200069627A1

Human necessities

Pharmaceutical compositions comprising DGLA and use of same

#19 | 2020-03-05

US20200069626A1

Human necessities

Compositions comprising 15-HEPE and methods of using the same

#20 | 2019-09-12

US20190274989A1

Human necessities

Pharmaceutical compositions comprising DGLA and use of same

#21 | 2019-09-05

US20190269639A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME

#22 | 2019-07-25

US20190224154A1

Human necessities

COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME

#23 | 2019-07-18

US20190216761A1

Human necessities

COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME

#24 | 2019-06-13

US20190175534A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME

#25 | 2018-11-22

US20180333382A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME

#26 | 2018-08-02

US20180214408A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME

#27 | 2018-07-19

US20180201566A1

Chemistry; metallurgy

Compositions comprising oxo-derivatives of fatty acids and methods of making and using same

#28 | 2018-05-31

US20180147173A1

Human necessities

Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease

#29 | 2018-04-19

US20180104208A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME

#30 | 2018-04-19

US20180104207A1

Human necessities

Compositions comprising 15-HEPE and methods of using the same

#31 | 2018-02-08

US20180036272A1

Human necessities

Pharmaceutical compositions comprising DGLA and use of same

#32 | 2018-01-11

US20180008567A1

Human necessities

COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME

#33 | 2017-08-17

US20170232021A1

Human necessities

COMPOSITIONS AND METHODS OF USING SAME

#34 | 2017-07-13

US20170196825A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME

#35 | 2017-06-22

US20170172965A1

Human necessities

Compositions comprising 15-HEPE and methods of using the same

#36 | 2017-03-16

US20170071890A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME

#37 | 2017-01-26

US20170020836A1

Human necessities

Compositions Comprising 15-HEPE and Methods of Treating or Preventing Cancer and Neurologic Disease

#38 | 2016-12-15

US20160362358A1

Chemistry; metallurgy

Compositions comprising oxo-derivatives of fatty acids and methods of making and using same

#39 | 2016-11-10

US20160324820A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING ASTHMA AND LUNG DISORDERS USING SAME

#40 | 2016-06-30

US20160184252A1

Human necessities

Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same

#41 | 2015-12-10

US20150352053A1

Human necessities

Pharmaceutical compositions comprising DGLA and use of same

#42 | 2015-10-15

US20150290225A1

Human necessities

COMPOSITIONS AND METHODS OF USING SAME

#43 | 2015-08-13

US20150224076A1

Human necessities

COMPOSITIONS COMPRISING 15-OHEPA AND METHODS OF USING THE SAME

#44 | 2015-07-16

US20150196521A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING ASTHMA AND LUNG DISORDERS USING SAME

#45 | 2015-04-02

US20150094370A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME

#46 | 2015-04-02

US20150093344A1

Human necessities

Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof

#47 | 2014-06-19

US20140171358A1

Human necessities

ANTIMICROBIAL COMPOSITIONS COMPRISING DGLA AND NEOMYCIN SULFATE AND METHODS OF USE THEREOF

#48 | 2013-12-12

US20130331448A1

Chemistry; metallurgy

Compositions comprising 20-carbon fatty acids and methods of making and using same

#49 | 2013-10-17

US20130274338A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME

#50 | 2013-10-10

US20130267598A1

Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA, 15-OHEPA, AND/OR 15-HETRE AND METHODS OF REDUCING SEBUM PRODUCTION USING SAME

#51 | 2013-04-25

US20130102575A1

Human necessities

Pharmaceutical compositions comprising DGLA, 15-HEPE, and/or 15-HETrE and methods of use thereof

#52 | 2013-04-25

US20130101533A1

Human necessities

Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof

#53 | 2012-10-18

US20120264705A1

Human necessities

ANTIMICROBIAL COMPOSITIONS COMPRISING 15-HETRE AND METHODS OF USE THEREOF

#54 | 2012-09-13

US20120232147A1

Human necessities

Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof

InventorID:

208897 ⎘